• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

LETTERE ALL’EDITORE - Letters to the Editors

Volume:

Biochimica Clinica 2022; 46(1) 083-085

Published on-line:

November 24, 2021

DOI:

10.19186/BC_2021.074

Download in PDF:
Authentication required

Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers

AUTHORS

Gian Luca Salvagno1,2, Brandon M. Henry3,4, Laura Pighi1,2, Simone De Nitto1,2, Gianluca Gianfilippi5, Giuseppe Lippi1
1Section of Clinical Biochemistry, University of Verona, Verona, Italy
2Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy
3Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
4Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio,Texas, USA
5Medical Direction, Pederzoli Hospital, Peschiera del Garda, Italy

ABSTRACT

REFERENCES